Epirium is a clinical-stage biopharmaceutical company that has developed unique insights related to the biology of mitochondrial biogenesis and tissue function, potentially resulting in novel therapeutic approaches to currently intractable neuromuscular diseases.

Pharmaceutical

Epirium

Epirium's headquarters in San Diego, CA, United States

Russell J. Cox

George Schreiner

Patrick Enright

Sandy Mahatme

Val Harding

Robert Booth

Eugenio Mercuri

John Day

Graham Johnson

Scott Delp

Paddy Shivanand

Paul Berns

Helen Blau

Charlotte Sumner

The Advisors team at Epirium provides strategic guidance and expert insights to support the development of novel therapeutics targeting neuromuscular diseases. Their deep expertise in mitochondrial biology and biopharmaceutical development ensures that Epirium's clinical strategies are scientifically sound and aligned with industry best practices.

Advisors

This department oversees the strategic direction and policy-making of the organization through its board members.

Board Governance

The Program and Project Management team at Epirium orchestrates the planning, execution, and oversight of product development initiatives, ensuring alignment with company strategies in mitochondrial biogenesis research. They coordinate cross-functional activities, manage timelines, and mitigate risks to advance therapeutic solutions for neuromuscular diseases.

Program and Project Management

This department oversees the management of chemical processes and financial operations.

Chemistry and Finance

The Scientific and Product Development team at Epirium focuses on advancing the understanding of mitochondrial biology and its therapeutic applications. They conduct cutting-edge research, develop clinical strategies, and oversee experimental design and chemical synthesis to drive the development of novel treatments for neuromuscular diseases.

Scientific and Product Development

The Leadership Team at Epirium is responsible for setting strategic direction and overseeing the overall operations of the company. This team, comprised of senior executives from various disciplines, collaborates to drive the development of innovative therapies for neuromuscular diseases, ensuring that scientific advancements align with financial and operational goals to facilitate successful clinical programs. Their collective expertise guides decision-making and fosters a culture of innovation essential for the company's growth and impact in the biopharmaceutical industry.

Epirium

Org chart

Board & advisors

Teams

Advisors

Board Governance

Program and Project Management

Chemistry and Finance

Scientific and Product Development

Leadership Team

Offices

Epirium

Org chart

Board & advisors

Teams

Advisors

Board Governance

Program and Project Management

Chemistry and Finance

Scientific and Product Development

Leadership Team

Offices

Related companies